Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.09 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics EV/EBITDA Ratio 2011-2024 | RVNC

Annual EV/EBITDA Ratio Revance Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.83 -5.24 -4.95 -4.01 -6.41 -6.13 -4.31 -2.88 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.88 -6.41 -4.84